EcoDrugPlus

Leukotriene B4 Receptor

Ensembl ID : ENSMAMG00000013220
Gene Symbol: LTB4R
3 Cross references
142 Possible Orthologues:

Leukotriene B4 Receptor 2a

Ensembl ID : ENSMAMG00000013225
Gene Symbol: LTB4R2A
3 Cross references
157 Possible Orthologues:

Leukotriene B4 Receptor 2b

Ensembl ID : ENSMAMG00000026521
Gene Symbol: LTB4R2B
3 Cross references
167 Possible Orthologues:

Lysine (K)-Specific Demethylase 1a

Ensembl ID : ENSMAMG00000006551
Gene Symbol: KDM1A
3 Cross references
212 Possible Orthologues:

Lysyl Oxidase-Like 2a

Ensembl ID : ENSMAMG00000018122
Gene Symbol: LOXL2A
3 Cross references
208 Possible Orthologues:

Lysyl Oxidase-Like 2b

Ensembl ID : ENSMAMG00000019870
Gene Symbol: LOXL2B
3 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSMAMG00000025624
Gene Symbol: MIF
2 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor A

Ensembl ID : ENSMAMG00000017177
Gene Symbol: MST1RA
2 Cross references
188 Possible Orthologues:

Macrophage Stimulating 1 Receptor B

Ensembl ID : ENSMAMG00000023360
Gene Symbol: MST1RB
2 Cross references
193 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSMAMG00000015702
Gene Symbol: MMP14A
3 Cross references
198 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSMAMG00000016212
Gene Symbol: MMP14B
3 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSMAMG00000003664
Gene Symbol: MMP2
3 Cross references
209 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).